A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinibAmir Hossein Daneshmanesh, Håkan Mellstedt, Anders Österborg et al.|PLoS ONE|2018Cited by 43
Effect of ROR1-targeting small molecules on chronic lymphocytic leukemia (CLL) cells.Håkan Mellstedt, Ali Moshfegh, Salam Khan et al.|Journal of Clinical Oncology|2012Cited by 7
A new class of compound for pancreatic carcinoma targeting the tyrosine kinase receptor (TKR) ROR1.Håkan Mellstedt, Anders Österborg, Amir Hossein Daneshmanesh et al.|Journal of Clinical Oncology|2014Cited by 5
A new class of anti-cancer drugs targeting the tyrosine kinase receptor ROR1 in CLL.Håkan Mellstedt, Ali Moshfegh, Salam Khan et al.|Journal of Clinical Oncology|2015Cited by 4
First-in-Class Oral Small Molecule Against the Tyrosine Kinase ROR1 (KAN0439834) Induced Significant Apoptosis of Chronic Lymphocytic Leukemia CellsMohammad Hojjat‐Farsangi, Håkan Mellstedt, Amir Hossein Daneshmanesh et al.|Blood|2017Cited by 1